Aspire Biopharma Holdings annual revenue
2022
2023
2024
2025
Aspire Biopharma Holdings Revenue Growth & History (ASBP)
Aspire Biopharma Holdings reported $6,202 in revenue for fiscal 2025.
View full Aspire Biopharma Holdings company overviewAspire Biopharma Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6,202 | $6,202 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
Aspire Biopharma Holdings quarterly revenue
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $63,104 | $63,104 | — |
| Q1 2026 | 2026-03-31 | $28,353 | $28,353 | — |
| Q4 2025 | 2025-12-31 | $4,261 | — | — |
| Q3 2025 | 2025-09-30 | $1,941 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
Aspire Biopharma Holdings revenue growth trends
Aspire Biopharma Holdings's latest reported quarter, Q2 2026, generated $63,104 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Aspire Biopharma Holdings source filings ↗